We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMS icon
326
Maximus
MMS
$3.32B
$206K ﹤0.01%
2,452
-2,825
-54% -$232K
ARIS
327
DELISTED
Aris Water Solutions
ARIS
$204K ﹤0.01%
14,400
-10,154
-41% -$103K
JWN
328
DELISTED
Nordstrom
JWN
$202K ﹤0.01%
+9,971
New +$189K
KDP icon
329
Keurig Dr Pepper
KDP
$42.8B
$200K ﹤0.01%
+6,531
New +$201K
HAIN icon
330
Hain Celestial
HAIN
$44.6M
$199K ﹤0.01%
+25,343
New +$250K
FOLD
331
DELISTED
Amicus Therapeutics
FOLD
$194K ﹤0.01%
+16,489
New +$211K
RUN icon
332
Sunrun
RUN
$2.26B
$189K ﹤0.01%
+14,319
New +$197K
LUNG icon
333
Pulmonx
LUNG
$52.8M
$188K ﹤0.01%
+20,289
New +$238K
KALV
334
DELISTED
KalVista Pharmaceuticals
KALV
$182K ﹤0.01%
+15,353
New +$205K
INOD icon
335
Innodata
INOD
$1.81B
$180K ﹤0.01%
+27,305
New +$227K
OSUR icon
336
OraSure Technologies
OSUR
$273M
$177K ﹤0.01%
28,755
+7,116
+33% +$51.7K
NVRO
337
DELISTED
NEVRO CORP.
NVRO
$175K ﹤0.01%
+12,135
New +$201K
HIMS icon
338
Hims & Hers Health
HIMS
$5.79B
$163K ﹤0.01%
10,521
-4,910
-32% -$55.4K
XERS icon
339
Xeris Biopharma Holdings
XERS
$1.45B
$163K ﹤0.01%
+73,570
New +$190K
MBI icon
340
MBIA
MBI
$275M
$161K ﹤0.01%
+23,856
New +$151K
PAHC icon
341
Phibro Animal Health
PAHC
$1.5B
$161K ﹤0.01%
+12,433
New +$149K
TERN
342
DELISTED
Terns Pharmaceuticals
TERN
$158K ﹤0.01%
24,060
+6,770
+39% +$44.2K
VERV
343
DELISTED
Verve Therapeutics
VERV
$153K ﹤0.01%
+11,504
New +$153K
ATEC icon
344
Alphatec Holdings
ATEC
$1.48B
$140K ﹤0.01%
+10,136
New +$150K
WEAV icon
345
Weave Communications
WEAV
$553M
$138K ﹤0.01%
11,989
+1,249
+12% +$15K
BRY
346
DELISTED
Berry Corp
BRY
$118K ﹤0.01%
+14,689
New +$103K
CERS icon
347
Cerus
CERS
$575M
$113K ﹤0.01%
+59,637
New +$122K
SABR icon
348
Sabre
SABR
$716M
$111K ﹤0.01%
+45,982
New +$154K
HCAT icon
349
Health Catalyst
HCAT
$160M
$111K ﹤0.01%
+14,713
New +$134K
STRO icon
350
Sutro Biopharma
STRO
$386M
$95.6K ﹤0.01%
+1,693
New +$74.8K
12 13
14
15 16

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.